Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

J Virol. 1996 Jan;70(1):520-32. doi: 10.1128/JVI.70.1.520-532.1996.

Abstract

Adeno-associated virus is an integrating DNA parvovirus with the potential to be an important vehicle for somatic gene therapy. A potential barrier, however, is the low transduction efficiencies of recombinant adeno-associated virus (rAAV) vectors. We show in this report that adenovirus dramatically enhances rAAV transduction in vitro in a way that is dependent on expression of early region 1 and 4 (E1 and E4, respectively) genes and directly proportional to the appearance of double-stranded replicative forms of the rAAV genome. Expression of the open reading frame 6 protein from E4 in the absence of E1 accomplished a similar but attenuated effect. The helper activity of adenovirus E1 and E4 for rAAV gene transfer was similarly demonstrated in vivo by using murine models of liver- and lung-directed gene therapy. Our data indicate that conversion of a single-stranded rAAV genome to a duplex intermediate limits transduction and usefulness for gene therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenovirus E1 Proteins / genetics
  • Adenovirus E1 Proteins / metabolism
  • Adenovirus E4 Proteins / genetics
  • Adenovirus E4 Proteins / metabolism
  • Animals
  • Cell Line
  • Chlorocebus aethiops
  • DNA, Single-Stranded / metabolism
  • DNA, Viral / biosynthesis
  • Dependovirus / genetics*
  • Genetic Therapy*
  • HeLa Cells
  • Humans
  • Lac Operon
  • Liver / virology
  • Lung / virology
  • Mice
  • Mice, Inbred BALB C
  • Open Reading Frames
  • Recombination, Genetic
  • Transformation, Genetic*
  • Vero Cells

Substances

  • Adenovirus E1 Proteins
  • Adenovirus E4 Proteins
  • DNA, Single-Stranded
  • DNA, Viral